IAM Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
IAM Advisory's XBI Position: Q2 2026 in Review
IAM Advisory increased its State Street SPDR S&P Biotech ETF (XBI) stake by 978% in Q2 2026, buying an estimated $2.34M and bringing the position to 19,117 shares worth $3.03M. The position accounts for 0.59% of the portfolio, ranked #25.
IAM Advisory first reported a position in XBI in Q1 2024 and has held it in 6 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- IAM Advisory held 19,117 shares of State Street SPDR S&P Biotech ETF worth $3.03M as of Q2 2026.
- IAM Advisory bought 17,344 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.34M.
- State Street SPDR S&P Biotech ETF made up 0.59% of IAM Advisory's portfolio in Q2 2026, its #25 holding.
- IAM Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 6 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on IAM Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.